210 related articles for article (PubMed ID: 31241338)
1. p53-Bad: A Novel Tumor Suppressor/Proapoptotic Factor Hybrid Directed to the Mitochondria for Ovarian Cancer Gene Therapy.
Lu P; Redd Bowman KE; Brown SM; Joklik-Mcleod M; Vander Mause ER; Nguyen HTN; Lim CS
Mol Pharm; 2019 Aug; 16(8):3386-3398. PubMed ID: 31241338
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53.
Lu P; Vander Mause ER; Redd Bowman KE; Brown SM; Ahne L; Lim CS
J Ovarian Res; 2019 May; 12(1):45. PubMed ID: 31092272
[TBL] [Abstract][Full Text] [Related]
3. Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer.
Bowman KR; Kim JH; Lim CS
J Ovarian Res; 2019 Apr; 12(1):38. PubMed ID: 31039796
[TBL] [Abstract][Full Text] [Related]
4. p53-Bad* Fusion Gene Therapy Induces Apoptosis In Vitro and Reduces Zebrafish Tumor Burden in Hepatocellular Carcinoma.
Bowman KER; Ahne L; O'Brien L; Vander Mause ER; Lu P; Wallis B; Evason KJ; Lim CS
Mol Pharm; 2023 Jan; 20(1):331-340. PubMed ID: 36490361
[TBL] [Abstract][Full Text] [Related]
5. Delivery of a monomeric p53 subdomain with mitochondrial targeting signals from pro-apoptotic Bak or Bax.
Matissek KJ; Okal A; Mossalam M; Lim CS
Pharm Res; 2014 Sep; 31(9):2503-15. PubMed ID: 24633417
[TBL] [Abstract][Full Text] [Related]
6. The Bad guy cooperates with good cop p53: Bad is transcriptionally up-regulated by p53 and forms a Bad/p53 complex at the mitochondria to induce apoptosis.
Jiang P; Du W; Heese K; Wu M
Mol Cell Biol; 2006 Dec; 26(23):9071-82. PubMed ID: 17000778
[TBL] [Abstract][Full Text] [Related]
7. Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC.
Kim CK; Choi EJ; Choi SH; Park JS; Haider KH; Ahn WS
Gynecol Oncol; 2003 Aug; 90(2):265-72. PubMed ID: 12893186
[TBL] [Abstract][Full Text] [Related]
8. Direct induction of apoptosis using an optimal mitochondrially targeted p53.
Mossalam M; Matissek KJ; Okal A; Constance JE; Lim CS
Mol Pharm; 2012 May; 9(5):1449-58. PubMed ID: 22380534
[TBL] [Abstract][Full Text] [Related]
9. The DNA binding domain of p53 is sufficient to trigger a potent apoptotic response at the mitochondria.
Matissek KJ; Mossalam M; Okal A; Lim CS
Mol Pharm; 2013 Oct; 10(10):3592-602. PubMed ID: 23968395
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo.
Ohtani S; Kagawa S; Tango Y; Umeoka T; Tokunaga N; Tsunemitsu Y; Roth JA; Taya Y; Tanaka N; Fujiwara T
Mol Cancer Ther; 2004 Jan; 3(1):93-100. PubMed ID: 14749479
[TBL] [Abstract][Full Text] [Related]
11. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene.
Tai YT; Strobel T; Kufe D; Cannistra SA
Cancer Res; 1999 May; 59(9):2121-6. PubMed ID: 10232598
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
Yan X; Fraser M; Qiu Q; Tsang BK
Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
[TBL] [Abstract][Full Text] [Related]
13. Resistance to p53-mediated growth suppression in human ovarian cancer cells retain endogenous wild-type p53.
Jin X; Burke W; Rothman K; Lin J
Anticancer Res; 2002; 22(2A):659-64. PubMed ID: 12014634
[TBL] [Abstract][Full Text] [Related]
14. The Proapoptotic Gene
Hung JC; Wu JL; Li HC; Chiu HW; Hong JR
Cells; 2021 Oct; 10(11):. PubMed ID: 34831043
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway.
Xiao X; Yang G; Bai P; Gui S; Nyuyen TM; Mercado-Uribe I; Yang M; Zou J; Li Q; Xiao J; Chang B; Liu G; Wang H; Liu J
BMC Cancer; 2016 Aug; 16():582. PubMed ID: 27484466
[TBL] [Abstract][Full Text] [Related]
16. Versatility of BCR/ABL-expressing leukemic cells in circumventing proapoptotic BAD effects.
Salomoni P; Condorelli F; Sweeney SM; Calabretta B
Blood; 2000 Jul; 96(2):676-84. PubMed ID: 10887134
[TBL] [Abstract][Full Text] [Related]
17. Interdependence of Bad and Puma during ionizing-radiation-induced apoptosis.
Toruno C; Carbonneau S; Stewart RA; Jette C
PLoS One; 2014; 9(2):e88151. PubMed ID: 24516599
[TBL] [Abstract][Full Text] [Related]
18. Requirement of nuclear localization and transcriptional activity of p53 for its targeting to the yolk syncytial layer (YSL) nuclei in zebrafish embryo and its use for apoptosis assay.
Chen GD; Chou CM; Hwang SP; Wang FF; Chen YC; Hung CC; Chen JY; Huang CJ
Biochem Biophys Res Commun; 2006 May; 344(1):272-82. PubMed ID: 16616005
[TBL] [Abstract][Full Text] [Related]
19. Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro.
Roy I; Holle L; Song W; Holle E; Wagner T; Yu X
Anticancer Res; 2002; 22(6A):3185-9. PubMed ID: 12530063
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of GSK3 attenuates DNA damage-induced apoptosis via reduction of p53 mitochondrial translocation and Bax oligomerization in neuroblastoma SH-SY5Y cells.
Ngok-Ngam P; Watcharasit P; Thiantanawat A; Satayavivad J
Cell Mol Biol Lett; 2013 Mar; 18(1):58-74. PubMed ID: 23161404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
